Literature DB >> 15731931

[A factorial trial of six interventions for the prevention of postoperative nausea and vomiting].

C C Apfel1, A Bacher, A Biedler, K Danner, O Danzeisen, L H J Eberhart, H Forst, G Fritz, M Hergert, G Frings, A Goebel, H-B Hopf, H Kerger, P Kranke, M Lange, F Mertzlufft, J Motsch, A Paura, N Roewer, E Schneider, K Stoecklein, J Wermelt, C Zernak.   

Abstract

BACKGROUND: Untreated, one third of patients who undergo surgery will have postoperative nausea and vomiting. Although many trials have been conducted, the relative benefits of prophylactic antiemetic interventions given alone or in combination remain unknown.
METHODS: In a randomized, controlled trial of factorial design, 5,199 patients at high risk for postoperative nausea and vomiting were randomly assigned to 1 of 64 possible combinations of 6 prophylactic interventions: 1) 4 mg of ondansetron or no ondansetron; 2) 4 mg of dexamethasone or no dexamethasone; 3) 1.25 mg of droperidol or no droperidol; 4) propofol or a volatile anesthetic; 5) nitrogen or nitrous oxide; 6) remifentanil or fentanyl. The primary aim parameter was nausea and vomiting within 24 h after surgery, which was evaluated blindly.
RESULTS: Ondansetron, dexamethasone, and droperidol each reduced the risk of postoperative nausea and vomiting by about 26%, propofol reduced the risk by 19%, and nitrogen by 12%. The risk reduction with both of these agents (i.e., total intravenous anesthesia) was thus similar to that observed with each of the antiemetics alone. All the interventions acted independently of each other and independently of the patients' baseline risk. Consequently, the relative risks associated with the combined interventions could be estimated by multiplying the relative risks associated with each intervention. However, absolute risk reduction was a critical function of patients' baseline risk.
CONCLUSIONS: Because antiemetic interventions are similarly effective and act independently, the safest or least expensive should be used first. Prophylaxis is rarely warranted in low-risk patients, moderate-risk patients may benefit from a single intervention, and multiple interventions should be reserved for high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731931     DOI: 10.1007/s00101-005-0803-8

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  31 in total

Review 1.  A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issues.

Authors:  M R Tramèr
Journal:  Acta Anaesthesiol Scand       Date:  2001-01       Impact factor: 2.105

2.  The cost-effective management of postoperative nausea and vomiting.

Authors:  M F Watcha
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

Review 3.  Comparison of predictive models for postoperative nausea and vomiting.

Authors:  C C Apfel; P Kranke; L H J Eberhart; A Roos; N Roewer
Journal:  Br J Anaesth       Date:  2002-02       Impact factor: 9.166

4.  An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT).

Authors:  Christian C Apfel; Kari Korttila; Mona Abdalla; Andreas Biedler; Peter Kranke; Stuart J Pocock; N Roewer
Journal:  Control Clin Trials       Date:  2003-12

Review 5.  How to study postoperative nausea and vomiting.

Authors:  C C Apfel; N Roewer; K Korttila
Journal:  Acta Anaesthesiol Scand       Date:  2002-09       Impact factor: 2.105

Review 6.  Postoperative nausea and emesis.

Authors:  Mehernoor F Watcha
Journal:  Anesthesiol Clin North Am       Date:  2002-09

7.  A survey of postoperative nausea and vomiting.

Authors:  M Koivuranta; E Läärä; L Snåre; S Alahuhta
Journal:  Anaesthesia       Date:  1997-05       Impact factor: 6.955

8.  The effective dose of dexamethasone for antiemesis after major gynecological surgery.

Authors:  K Liu; C C Hsu; Y Y Chia
Journal:  Anesth Analg       Date:  1999-11       Impact factor: 5.108

9.  The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting.

Authors:  J Tang; B Wang; P F White; M F Watcha; J Qi; R H Wender
Journal:  Anesth Analg       Date:  1998-02       Impact factor: 5.108

10.  Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial.

Authors:  A L Kovac; T A O'Connor; M H Pearman; L J Kekoler; D Edmondson; V L Baughman; J J Angel; C Campbell; H G Jense; M Mingus; M B Shahvari; M R Creed
Journal:  J Clin Anesth       Date:  1999-09       Impact factor: 9.452

View more
  10 in total

1.  Comparison of recovery characteristics, postoperative nausea and vomiting, and gastrointestinal motility with total intravenous anesthesia with propofol versus inhalation anesthesia with desflurane for laparoscopic cholecystectomy: A randomized controlled study.

Authors:  B Cagla Ozbakis Akkurt; Muhyittin Temiz; Kerem Inanoglu; Ahmet Aslan; Selim Turhanoglu; Zeynel Asfuroglu; Elif Canbolant
Journal:  Curr Ther Res Clin Exp       Date:  2009-04

2.  [Clinical pathway "laparoscopic prostatectomy". Analysis of anesthesiological procedures in a randomized study].

Authors:  J-P Braun; M Walter; M Lein; J Roigas; B Schwilk; M Moshirzadeh; K Eveslage; B Rehberg-Klug; D Hansen; C Spies
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

3.  An Electronic Medical Record-Derived Individualized Performance Metric to Measure Risk-Adjusted Adherence with Perioperative Prophylactic Bundles for Health Care Disparity Research and Implementation Science.

Authors:  Michael H Andreae; Stephan R Maman; Abrahm J Behnam
Journal:  Appl Clin Inform       Date:  2020-07-29       Impact factor: 2.342

4.  [Dolasetron and shivering. A prospective randomized placebo-controlled pharmaco-economic evaluation].

Authors:  M Bock; M Bauer; L Rösler; B Sinner; J Motsch
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

5.  Effect of Dexmedetomidine Compared to Remifentanil During Bariatric Surgery on Postoperative Nausea and Vomiting: a Retrospective Study.

Authors:  Sun Woo Nam; Ah-Young Oh; Bon-Wook Koo; Bo Young Kim; Jiwon Han; Jiwon Yoon
Journal:  Obes Surg       Date:  2022-08-17       Impact factor: 3.479

Review 6.  [Nausea and vomiting in the postoperative phase. Expert- and evidence-based recommendations for prophylaxis and therapy].

Authors:  C C Apfel; P Kranke; S Piper; D Rüsch; H Kerger; M Steinfath; K Stöcklein; D R Spahn; T Möllhoff; K Danner; A Biedler; M Hohenhaus; B Zwissler; O Danzeisen; H Gerber; F-J Kretz
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

7.  Phenothiazine vs 5HT3 antagonist prophylactic regimens to prevent Post-Anesthesia Care Unit rescue antiemetic: an observational study.

Authors:  Joseph R Ruiz; Joe E Ensor; Jeffrey W Lim; Antoinette Van Meter; Thomas F Rahlfs
Journal:  Open J Anesthesiol       Date:  2015-02

8.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Authors:  Stephanie Weibel; Gerta Rücker; Leopold Hj Eberhart; Nathan L Pace; Hannah M Hartl; Olivia L Jordan; Debora Mayer; Manuel Riemer; Maximilian S Schaefer; Diana Raj; Insa Backhaus; Antonia Helf; Tobias Schlesinger; Peter Kienbaum; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2020-10-19

9.  Effects of remifentanil versus nitrous oxide on postoperative nausea, vomiting, and pain in patients receiving thyroidectomy: Propensity score matching analysis.

Authors:  Min Kyoung Kim; Myung Sub Yi; Hyun Kang; Geun-Joo Choi
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

10.  The effects of tramadol on postoperative shivering after sevoflurane and remifentanil anesthesia.

Authors:  Taku Nakagawa; Miki Hashimoto; Yasunori Hashimoto; Kazuhiro Shirozu; Sumio Hoka
Journal:  BMC Anesthesiol       Date:  2017-01-03       Impact factor: 2.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.